Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16.
Source: insidermonkey.com
Stay updated with breaking news from Etzer Dament. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16.